MORGAN STANLEY

Holdings History for AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$261,938	229,770	+39,000	+20%	$1.14	Q4 2025
30 Sep 2025	0%	+0%	$242,278	190,770	+12,527	+7%	$1.27	Q3 2025
30 Jun 2025	0%	+0%	$188,938	178,243	+177,943	+59314%	$1.06	Q2 2025
31 Mar 2025	0%	0%	$408	300	0		$1.36	Q1 2025
31 Dec 2024	0%	0%	$414	300	-3		$1.38	Q4 2024
30 Sep 2024	0%	-0%	$324	303	-17,158		$1.07	Q3 2024
30 Jun 2024	0%	+0%	$37,541	17,461	+13,297	+300%	$2.15	Q2 2024
31 Mar 2024	0%	0%	$13,533	4,164	+833	+25%	$3.25	Q1 2024
31 Dec 2023	0%	+0%	$68,252	3,331	+546	+20%	$20.49	Q4 2023
30 Sep 2023	0%	-0%	$44,783	2,785	-39,457	-93%	$16.08	Q3 2023
30 Jun 2023	0%	-0%	$359,058	42,242	-3,290	-7.2%	$8.50	Q2 2023
31 Mar 2023	0%	+0%	$449,401	45,532	+4,227	+10%	$9.87	Q1 2023
31 Dec 2022	0%	+0%	$393,637	41,305	+1,124	+2.8%	$9.53	Q4 2022
30 Sep 2022		0%	$1,000	47	0		$21.28 ^*	Q3 2022
30 Sep 2022	0%	0%	$698,000	40,181	+50	+0.12%	$17.37	Q3 2022
30 Jun 2022		0%	$2,000	200	0		$10.00 ^*	Q2 2022
30 Jun 2022	0%	+0%	$311,000	40,131	+39,446	+5759%	$7.75	Q2 2022
31 Mar 2022	0%	+0%	$10,000	685	+685	NEW	$14.60	Q1 2022
31 Mar 2022		0%	$4,000	200	0		$20.00 ^*	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.